User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Prostate Cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Primary tabs

download
  • Open access
  • PDF
  • 544.88 K
Parker, Chris Castro, Elena Fizazi, Karim Heidenreich, Axel Ost, Piet Tombal, Bertrand [UCL] ESMO Guidelines Commitee

(eng) SCREENING AND EARLY DETECTION : Subclinical prostate cancer is common in men >50 years. Population-based screening of men aged between 55 and 69 years, using prostate-specific antigen (PSA) testing, has been evaluated.1 After a median follow-up of 16 years, the European screening trial demonstrated a 25% relative reduction in prostate cancer mortality. However, 570 men needed to be invited for screening and 18 patients needed to be treated to prevent one death from prostate cancer, and there was no effect on overall survival (OS). [...]

Document type Article de périodique (Journal article) – Article de recherche
Access type Accès libre
Publication date 2020
Language Anglais
Journal information "Annals of oncology" - Vol. 31, no. 9, p. 1119-1134 (2020)
Peer reviewed yes
Publisher Elsevier ((United Kingdom) London)
issn 0923-7534
e-issn 1569-8041
Publication status Publié
Affiliations UCL - SSS/IREC/CHEX - Pôle de chirgurgie expérimentale et transplantation
UCL - (SLuc) Service d'urologie
Keywords chemotherapy ; hormone therapy ; prostate cancer ; radiotherapy ; surgery
Links
Bibliographic reference Parker, Chris ; Castro, Elena ; Fizazi, Karim ; Heidenreich, Axel ; Ost, Piet ; et. al. Prostate Cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.. In: Annals of oncology, Vol. 31, no. 9, p. 1119-1134 (2020)
Permanent URL http://hdl.handle.net/2078.1/230976